• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小胶质细胞嘌呤能受体在痛觉信号转导中的作用。

The Role of Microglial Purinergic Receptors in Pain Signaling.

机构信息

Department of Pharmacology, School of Pharmacy at Fukuoka, International University of Health and Welfare, 137-1 Enokizu, Okawa 831-8501, Japan.

Institute for Advanced Study, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

出版信息

Molecules. 2022 Mar 16;27(6):1919. doi: 10.3390/molecules27061919.

DOI:10.3390/molecules27061919
PMID:35335282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8949888/
Abstract

Pain is an essential modality of sensation in the body. Purinergic signaling plays an important role in nociceptive pain transmission, under both physiological and pathophysiological conditions, and is important for communication between both neuronal and non-neuronal cells. Microglia and astrocytes express a variety of purinergic effectors, and a variety of receptors play critical roles in the pathogenesis of neuropathic pain. In this review, we discuss our current knowledge of purinergic signaling and of the compounds that modulate purinergic transmission, with the aim of highlighting the importance of purinergic pathways as targets for the treatment of persistent pain.

摘要

疼痛是身体感觉的基本方式。嘌呤能信号在生理和病理生理条件下的伤害性疼痛传递中起着重要作用,并且对于神经元和非神经元细胞之间的通讯很重要。小胶质细胞和星形胶质细胞表达多种嘌呤能效应器,多种受体在神经病理性疼痛的发病机制中发挥关键作用。在这篇综述中,我们讨论了我们对嘌呤能信号转导以及调节嘌呤能传递的化合物的现有认识,目的是强调嘌呤能途径作为治疗持续性疼痛的靶点的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21cd/8949888/2da7195ed5e6/molecules-27-01919-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21cd/8949888/7ed60e117d1d/molecules-27-01919-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21cd/8949888/0596ec63e4da/molecules-27-01919-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21cd/8949888/6ce401004962/molecules-27-01919-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21cd/8949888/f4651cfe566f/molecules-27-01919-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21cd/8949888/2da7195ed5e6/molecules-27-01919-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21cd/8949888/7ed60e117d1d/molecules-27-01919-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21cd/8949888/0596ec63e4da/molecules-27-01919-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21cd/8949888/6ce401004962/molecules-27-01919-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21cd/8949888/f4651cfe566f/molecules-27-01919-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21cd/8949888/2da7195ed5e6/molecules-27-01919-g005.jpg

相似文献

1
The Role of Microglial Purinergic Receptors in Pain Signaling.小胶质细胞嘌呤能受体在痛觉信号转导中的作用。
Molecules. 2022 Mar 16;27(6):1919. doi: 10.3390/molecules27061919.
2
Purinergic system, microglia and neuropathic pain.嘌呤能系统、小胶质细胞与神经病理性疼痛。
Curr Opin Pharmacol. 2012 Feb;12(1):74-9. doi: 10.1016/j.coph.2011.10.014. Epub 2011 Oct 27.
3
Purinergic systems, neuropathic pain and the role of microglia.嘌呤能系统、神经病理性疼痛和小胶质细胞的作用。
Exp Neurol. 2012 Apr;234(2):293-301. doi: 10.1016/j.expneurol.2011.09.016. Epub 2011 Sep 17.
4
Neuron-microglia interaction by purinergic signaling in neuropathic pain following neurodegeneration.神经变性后神经性疼痛中嘌呤能信号介导的神经元-小胶质细胞相互作用。
Neuropharmacology. 2016 May;104:76-81. doi: 10.1016/j.neuropharm.2015.08.042. Epub 2015 Aug 29.
5
Purinergic signalling in spinal pain processing.嘌呤能信号在脊髓疼痛处理中的作用。
Purinergic Signal. 2021 Mar;17(1):49-54. doi: 10.1007/s11302-020-09748-5. Epub 2020 Nov 10.
6
P2 receptors, microglial cytokines and chemokines, and neuropathic pain.P2 受体、小胶质细胞细胞因子和趋化因子与神经性疼痛
J Neurosci Res. 2017 Jun;95(6):1319-1329. doi: 10.1002/jnr.23816. Epub 2016 Jul 4.
7
The known knowns of microglia-neuronal signalling in neuropathic pain.小胶质细胞-神经元信号在神经病理性疼痛中的已知因素。
Neurosci Lett. 2013 Dec 17;557 Pt A:37-42. doi: 10.1016/j.neulet.2013.08.037. Epub 2013 Aug 27.
8
Pain and purinergic signaling.疼痛与嘌呤能信号传导
Brain Res Rev. 2010 May;63(1-2):222-32. doi: 10.1016/j.brainresrev.2009.11.003. Epub 2009 Nov 18.
9
ATP receptors gate microglia signaling in neuropathic pain.三磷酸腺苷受体调控神经病理性疼痛中的小胶质细胞信号转导。
Exp Neurol. 2012 Apr;234(2):354-61. doi: 10.1016/j.expneurol.2011.11.012. Epub 2011 Nov 16.
10
Role of purinergic receptors in CNS function and neuroprotection.嘌呤能受体在中枢神经系统功能和神经保护中的作用。
Adv Pharmacol. 2011;61:495-528. doi: 10.1016/B978-0-12-385526-8.00015-1.

引用本文的文献

1
Time-restricted feeding modulates neuron-glial interactions and circadian rhythm in the spinal cord of male Wistar rats fed a high-fat diet.限时进食可调节高脂饮食喂养的雄性Wistar大鼠脊髓中的神经元-胶质细胞相互作用和昼夜节律。
Spinal Cord. 2025 Jul 14. doi: 10.1038/s41393-025-01106-9.
2
Evaluation of the Efficacy of the Addition of a Combination of Pyrimidine Nucleotides and Vitamin B1 and B12 to Standard Treatment in the Management of Painful Radiculopathy and in the Quality of Life of Patients.评估在标准治疗基础上加用嘧啶核苷酸与维生素B1和B12联合用药对疼痛性神经根病的治疗效果及患者生活质量的影响。
Nutrients. 2024 Dec 4;16(23):4187. doi: 10.3390/nu16234187.
3

本文引用的文献

1
Allosteric Modulation of Adenosine A Receptors as a New Therapeutic Avenue.别构调节腺苷 A 受体作为一种新的治疗途径。
Int J Mol Sci. 2022 Feb 14;23(4):2101. doi: 10.3390/ijms23042101.
2
Design, Synthesis, and Bioevaluation of 2-Aminopteridin-7(8)-one Derivatives as Novel Potent Adenosine A Receptor Antagonists for Cancer Immunotherapy.设计、合成和生物评价 2-氨基喋啶-7(8)-酮衍生物作为新型强效腺嘌呤 A 受体拮抗剂用于癌症免疫治疗。
J Med Chem. 2022 Mar 10;65(5):4367-4386. doi: 10.1021/acs.jmedchem.1c02199. Epub 2022 Feb 25.
3
Synthesis and Structure-Activity Relationship Studies of Benzimidazole-4,7-dione-Based P2X3 Receptor Antagonists as Novel Anti-Nociceptive Agents.
The Role of the Thalamus in Nociception: Important but Forgotten.
丘脑在伤害感受中的作用:重要却被遗忘。
Brain Sci. 2024 Jul 25;14(8):741. doi: 10.3390/brainsci14080741.
4
Ectonucleotidase inhibitors: targeting signaling pathways for therapeutic advancement-an in-depth review.外核苷酸酶抑制剂:靶向信号通路以促进治疗进展——深入综述
Purinergic Signal. 2025 Apr;21(2):221-265. doi: 10.1007/s11302-024-10031-0. Epub 2024 Jul 3.
5
Neuropathic pain: Mechanisms and therapeutic strategies.神经性疼痛:机制与治疗策略。
Front Cell Dev Biol. 2023 Jan 16;11:1072629. doi: 10.3389/fcell.2023.1072629. eCollection 2023.
6
Inhibition of P2X7 receptors by Lu AF27139 diminishes colonic hypersensitivity and CNS prostanoid levels in a rat model of visceral pain.P2X7 受体抑制剂 Lu AF27139 可减轻内脏痛大鼠模型的结肠高敏性和中枢前列腺素水平。
Purinergic Signal. 2022 Dec;18(4):499-514. doi: 10.1007/s11302-022-09892-0. Epub 2022 Aug 24.
7
The Role of Microglia in Neuroinflammation of the Spinal Cord after Peripheral Nerve Injury.小胶质细胞在周围神经损伤后脊髓神经炎症中的作用。
Cells. 2022 Jun 30;11(13):2083. doi: 10.3390/cells11132083.
苯并咪唑-4,7-二酮类 P2X3 受体拮抗剂的合成及构效关系研究作为新型抗伤害感受药物。
Molecules. 2022 Feb 16;27(4):1337. doi: 10.3390/molecules27041337.
4
Targeting the A adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice.靶向 A 腺苷受体以预防和逆转小鼠化疗引起的神经毒性。
Acta Neuropathol Commun. 2022 Jan 29;10(1):11. doi: 10.1186/s40478-022-01315-w.
5
Involvement of P2X7 receptors in chronic pain disorders.P2X7 受体在慢性疼痛障碍中的作用。
Purinergic Signal. 2022 Mar;18(1):83-92. doi: 10.1007/s11302-021-09796-5. Epub 2021 Nov 20.
6
Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors.人 P2X4 受体上 5-BDBD 的负变构调节的结构基础。
Mol Pharmacol. 2022 Jan;101(1):33-44. doi: 10.1124/molpharm.121.000402. Epub 2021 Oct 30.
7
Randomised trial of the P2X receptor antagonist sivopixant for refractory chronic cough.随机对照试验评估 P2X 受体拮抗剂西维派嗪治疗难治性慢性咳嗽。
Eur Respir J. 2022 Jun 2;59(6). doi: 10.1183/13993003.00725-2021. Print 2022 Jun.
8
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers.依利帕昔单抗是一种选择性 P2X3 受体拮抗剂,用于治疗与敏化神经纤维相关的疾病。
Sci Rep. 2021 Oct 6;11(1):19877. doi: 10.1038/s41598-021-99177-0.
9
Discovery of clinical candidate Sivopixant (S-600918): Lead optimization of dioxotriazine derivatives as selective P2X3 receptor antagonists.临床候选药物 Sivopixant(S-600918)的发现:作为选择性 P2X3 受体拮抗剂的二恶嗪衍生物的先导优化。
Bioorg Med Chem Lett. 2021 Nov 15;52:128384. doi: 10.1016/j.bmcl.2021.128384. Epub 2021 Sep 26.
10
Positive allosteric mechanisms of adenosine A receptor-mediated analgesia.腺苷 A 受体介导的镇痛的正变构机制。
Nature. 2021 Sep;597(7877):571-576. doi: 10.1038/s41586-021-03897-2. Epub 2021 Sep 8.